Pasithea Therapeutics Corp. · NASDAQ:KTTA
Ameriprise Financial Inc reported a 5.40% stake in Pasithea Therapeutics Corp. (Schedule 13G/A)
Event Mar 31, 2026 · Filed May 15, 2026
Ameriprise Financial Inc reported a 5.40% stake in Pasithea Therapeutics Corp., 1,350,896 shares, as a passive investor on Mar 31, 2026. Filed May 15, 2026 (Schedule 13G/A).
- Stake
- 5.40%
- Shares
- 1,350,896
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Ameriprise Financial, Inc. | 5.40% | 1,350,896 |
| Columbia Management Investment Advisers, LLC | 5.40% | 1,350,896 |
Source
Related
- Pasithea Therapeutics Corp.
- Ameriprise Financial Inc
- Pasithea Therapeutics Corp. shareholders
- Schedule 13G · Ameriprise Financial Inc · Feb 17, 2026
- Schedule 13G/A · Vivo Opportunity, LLC · Aug 14, 2026
- Schedule 13G/A · Opaleye Management Inc. · Jul 31, 2026
- Schedule 13G/A · Coastlands Capital LP · Jul 1, 2026
- Schedule 13G · Stonepine Capital Management, LLC · Jun 23, 2026
- Form 4 · Coastlands Capital LP · Jun 22, 2026